Impact of comorbidities on ischemic stroke outcomes in women

Stroke

Volumn 39, Issue 7, 2008, Pages 2138-2140

  Bushnell, Cheryl D ^a,d   Lee, Jeanne ^b   Duncan, Pamela W ^b   Newby, L Kristin ^c   Goldstein, Larry B ^a  

^a Center for Cerebrovascular Disease   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Acute stroke; Comorbidities; Outcome; Stroke recovery; Women and minorities

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL STATUS; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RISK FACTOR; BRAIN ISCHEMIA; COHORT ANALYSIS; CORONARY ARTERY DISEASE; LETTER; MIDDLE AGED; STROKE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; COHORT STUDIES; COMORBIDITY; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); STROKE; TREATMENT OUTCOME;

EID: 47649090157     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.509281     Document Type: Article

References (13)

1. Kelly-Hayes M, Beiser AS, Kase C, Scaramucci A, D'Agostino RB, Wolf PA. The influence of gender and age on disability following ischemic stroke: The framingham study. J Stroke Cerebrovasc Diseases. 2003;12: 119-126.
2. Glader E-L, Stegmayr B, Norrving B, Terent A, Hulter-Asberg K, Wester P-O, Asplund K. Sex differences in management and outcome after stroke. A swedish national perspective. Stroke. 2003;34:1970 -1975.
3. Kapral MK, Fang J, Hill MD, Silver F, Richars J, Jaigobin C, Cheung AM. Sex differences in stroke care and outcomes. Results from the registry of the canadian stroke network. Stroke. 2005;36:809-814.
4. Di Carlo A, Lamassa M, Baldreschi M, Pracucci G, Basile AM, Wolfe CD, Giroud M, Rudd A, Ghetti A, Inzitari D. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in europe. Data from a multicenter multinational hospital-based registry. Stroke. 2003;34:1114-1119.
5. Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Diseases. 1987;40:373-383.
6. Goldstein LB, Samsa GP, Matchar D, Horner R. Charlson index comor-bidity adjustment for ischemic stroke outcome studies. Stroke. 2004;35: 1941-1945.
7. Bushnell CD, Samsa GP, Goldstein LB. Hormone replacement therapy and ischemic stroke severity in women: A case control study. Neurology. 2001;56:1304-1307.
8. Stroke-1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the who task force on stroke and other cerebrovascular disorders. Stroke. 1989;20:1407-1431.
9. The national institute of neurological disorders; stroke rt-pa stroke study group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
10. Dombovy M, Basford J, Whisnant J, Bergstrahl E. Disability and use of rehabilitation services following stroke in rochester, minnesota, 1975-1979. Stroke. 1987;18:830-836.
11. Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard B, Kooperberg C, Rossouw JE, Trevisan M, Aragaki AK, Baird A, Bray PF, Buring J, Criqui M, Herrington D, Lynch JK, Rapp SR, Torner J. Effects of conjugated equine estrogen on stroke in the women's health initiative. Circulation. 2006;113:2425-2434.
12. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med. 2001;345:1243-1249.
13. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 1996;335: 453-461.